Ambagon Therapeutics
Biotechnology company developing cancer molecule therapeutics.
Eindhoven, Netherlandswww.ambagontx.com ↗
Total raised
€75M
€75,168,488
Funding rounds
1
Investors
8
distinct backers
Active since
2022-01
latest 2022-01
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood32
base rate 44% for Series A
- ▼ Overdue vs cohort gap
- ▼ Low backer re-investment
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-01-07 | Series A | €75M | AbbVie Ventures,Droia Ventures,Inkef Capital,Mission BioCapital,MRL Ventures Fund,Nextech Invest+2 more | View deal → |
Investors
8Related news
- Biotech startup Ambagon Therapeutics raises €75.1M from Amsterdam-based Inkef Capital, otherssiliconcanals.com · 2022-01
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Picnic€1.7BNetherlands · E-commerce
- Just Eat Takeaway€1.6BNetherlands · Foodtech
- Nebius€1.5BNetherlands · Cloud
- Roivant Sciences€1.2BSwitzerland · Healthtech